These in silico assessments suggest that their neuroprotective potential could potentially be mediated by interaction with glycogen synthase kinase-3 beta (GSK-3β), a serine/threonine kinase that plays a leading role in the cascade of events associated with AD. This evidence concerns the gene GSK3B and Alzheimer disease.